Legionella pneumophila serotype 1 pneumonia in patient receiving adalimumab

Emerging Infectious Diseases

Volumn 18, Issue 11, 2012, Pages 1872-1874

  Wuerz, Terry C ^a   Mooney, Owen ^a   Keynan, Yoav ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALANINE AMINOTRANSFERASE; ANTICOAGULANT AGENT; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; AZITHROMYCIN; CEFTRIAXONE; COTRIMOXAZOLE; CREATININE; LEVOFLOXACIN; RIFAMPICIN; VANCOMYCIN;

ABNORMAL RESPIRATORY SOUND; ACIDEMIA; ACIDOSIS; ACUTE DISEASE; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GRANULATION TISSUE; HUMAN; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LUNG EMBOLISM; PNEUMONIA; RADIOGRAPHY; RHEUMATOID ARTHRITIS; STENOTROPHOMONAS MALTOPHILIA; WHEEZING;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; LUNG; PNEUMONIA; SEROTYPING;

EID: 84867883084     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1811.111505     Document Type: Article

References (10)

1. Stout JE, Yu VL. Legionellosis. N Engl J Med. 1997;337:682-7. http://dx.doi.org/10.1056/NEJM199709043371006
2. Crum NF, Lederman ER, Wallace MR. Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore). 2005;84:291-302. http://dx.doi.org/10.1097/01. md.0000180044.19285.9a
3. Hofmann A, Beaulieau Y, Bernard F, Rico F. Fulminant legionellosis in two patients treated with infliximab for Crohn's disease: case series and literature review. Can J Gastroenterol. 2009;23:829-33.
4. Boivin S, Lacombe MC, Lalancette L, Allard A, Bordeleau M, Laverdure G. Environmental factors associated with nosocomial legionellosis after anti-tumor necrosis factor therapy: case study. Am J Infect Control. 2012;40:470-3.
5. Fabroni C, Gori A, Prignano F, Lotti T. A severe complication of anti-TNF treatment. G Ital Dermatol Venereol. 2010;145:775-7.
6. Tan MJ, Tan JS, Hamor RH, File TM Jr, Breiman RF. The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group. Chest. 2000;117:398-403. http://dx.doi.org/10.1378/chest.117.2.398
7. Tubach F, Ravaud P, Salmon-Ceron D, Petitpain N, Brocq O, Grados F, et al. Emergence of Legionella pneumophila pneumonia in patients receiving tumor-necrosis factor-α antagonists. Clin Infect Dis. 2006;43:e95-100. http://dx.doi.org/10.1086/508538
8. Tubach F, Salmon D, Lortholary O, Chosidow O, Bretagne S, Nicolas N et al. The risk of Legionella pneumophila infection in patients treated with anti-TNF. Results of the French 3-year prospective RATIO observatory. Poster presentation from the European League Against Rheumatism (EULAR) Congress; June 16-19, 2010; Rome, Italy. Abstract SAT0113.
9. McHugh SL, Newton CA, Yamamoto Y, et al. Tumor necrosis factor induces resistance of macrophages to Legionella pneumophila infection. Proc Soc Exp Biol Med. 2000;224:191-6. http://dx.doi. org/10.1046/j.1525-1373.2000.22420.x
10. Fujita M, Ikegame S, Harada E, et al. TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in mice. Cytokine. 2008;44:298-303. http://dx.doi. org/10.1016/j.cyto.2008.08.015